Miach Orthopaedics Appoints Patrick McBrayer President & CEO

Westborough, MA, September 7, 2022 (Business Wire) -- Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced healthcare industry veteran Patrick McBrayer has been appointed president and chief executive officer.

McBrayer has led companies in orthopaedics and regenerative medicine for more than 35 years and has also been an advisor to medical device companies in spine, orthopaedics and biotechnology. At Miach, McBrayer will lead the early-stage company that recently launched the BEAR Implant commercially in the U.S. through a direct sales force.

“The team at Miach Orthopaedics has made tremendous progress over the last year in driving market adoption of the BEAR Implant for ACL restoration,” said Patrick McBrayer, president and CEO, Miach Orthopaedics. “Surgeons and patients alike understand the benefits of healing a torn ACL rather than replacing it, and I look forward to leading Miach as we work to establish the BEAR Implant as the new standard of care for ACL tear surgery.”

McBrayer replaces Christopher Joyce, who served as interim president and CEO since Martha Shadan left the company in June. Joyce will return to his previous role as chief financial officer.

“We’re excited to welcome Patrick, who has a long track record of leading early-stage companies. His knowledge and experience will be invaluable as Miach continues to disrupt the treatment of ACL tears with the BEAR Implant,” said Joyce Erony, chairwoman of the Miach board of directors and managing partner at Amzak Health. “On behalf of the board, I also want to express our sincerest thanks to Chris for his leadership during this period of transition.”